MedPath

Influence of Anesthetic Temperature on Cephalad Sensory Blockade With Spinal Anesthesia

Not Applicable
Completed
Conditions
Cesarean Delivery
Interventions
Drug: bupivacaine/fentanyl/morphine
Registration Number
NCT00815022
Lead Sponsor
Nanjing Medical University
Brief Summary

Several factors influence the extension of anesthetic mixture during spinal anesthesia including anesthetic gravity, body position, drug volume, and drug-delivering velocity. However, the effect of temperature of anesthetic mixture on the cephalad sensory blockade is hitherto unknown. The investigators hypothesized that different temperatures of the anesthetic mixture had different velocity of extension after spinal anesthesia. In addition, previous studies suggest that parturients have relative higher sensitivity to temperature. Herein the investigators proposed that the temperature of anesthetic mixture had more extensive effect on the cephalad sensory blockade with spinal anesthesia for cesarean delivery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
400
Inclusion Criteria
  1. Nulliparous women
  2. > 18 years and < 45 years
Exclusion Criteria
  1. Allergy to opioids, a history of the use of centrally-acting drugs of any sort, chronic pain and psychiatric diseases records
  2. Participants younger than 18 years or older than 45 years
  3. Those who were not willing to or could not finish the whole study at any time
  4. Alcohol addictive or narcotic dependent patients
  5. Subjects with a nonvertex presentation
  6. Diagnosed diabetes mellitus and pregnancy-induced hypertension
  7. Twin gestation and breech presentation
  8. Pregnant fever

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1bupivacaine/fentanyl/morphineMixture of anesthetic including hyperbaric bupivacaine 12 mg, fentanyl 10 microg and morphine 200 microg, with the temperature of 20 degree celsius
2bupivacaine/fentanyl/morphineMixture of anesthetic including hyperbaric bupivacaine 12 mg, fentanyl 10 microg and morphine 200 microg, with the temperature of 10 degree celsius
3bupivacaine/fentanyl/morphineMixture of anesthetic including hyperbaric bupivacaine 12 mg, fentanyl 10 microg and morphine 200 microg, with the temperature of 15 degree celsius
4bupivacaine/fentanyl/morphineMixture of anesthetic including hyperbaric bupivacaine 12 mg, fentanyl 10 microg and morphine 200 microg, with the temperature of 25 degree celsius
5bupivacaine/fentanyl/morphineMixture of anesthetic including hyperbaric bupivacaine 12 mg, fentanyl 10 microg and morphine 200 microg, with the temperature of 30 degree celsius
6bupivacaine/fentanyl/morphineMixture of anesthetic including hyperbaric bupivacaine 12 mg, fentanyl 10 microg and morphine 200 microg, with the temperature of 35 degree celsius
Primary Outcome Measures
NameTimeMethod
Maximum cephalad sensory blockade to pinprick, cold and touchFrom the delivery of anesthetic mixture to 15 min immediate after spinal anesthesia
Secondary Outcome Measures
NameTimeMethod
Velocity of the sensory blockade at identical body positionFrom the delivery of anesthetic mixture to 15 min immediate after spinal anesthesia
The total dose of phenylephrine required to maintain baseline arterial blood pressureFrom the delivery of anesthetic mixture to 25 min after spinal anesthesia
Time interval of the occurrence of the hypotensionFrom the delivery of the anesthetic mixture to 25 min after spinal anesthesia

Trial Locations

Locations (1)

Nanjing Maternal and Child Health Care Hospital

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath